[1]
Safaie, S., Mir Mohammad Sadeghi, H. and Mir Mohammad Sadeghi, Z. 2018. Association of insertion/deletion mutations in angiotensin converting enzyme (ACE) gene and effectiveness of Glibenclamide therapy in Iranian type 2 diabetic patients. International Pharmacy Acta. 1, 1 (Mar. 2018), 75–75. DOI:https://doi.org/10.22037/ipa.v1i1.20594.